// App-Quantinova.ai

: Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD)

Researchers

Presenter

  • Tom Wilkinson

Principal Investigators

  • Stuart Schembri

  • Christopher Brightling

  • Nawar Diar Bakerly

  • William Macnee

  • Lars Rombo

  • Jan Hedner

  • Martin Allen

  • Paul Walker

  • Iris De Ryck

  • Annaelisa Tasciotti

  • Daniela Casula

  • Marco Testa

  • Ashwani Kumar Arora

Medical Centers

  • Southampton University, Faculty of Medicine, Southampton, United Kingdom

  • Scottish Centre for Respiratory Research, Ninewells Hospital, University of Dundee, Dundee, United Kingdom,

  • Institute for Lung Health, University of Leicester, Glenfield Hospital, Leicester, United Kingdom.

  • Salford Royal NHS Foundation Trust, Salford, United Kingdom

  • Clinical Research Centre, Sörmland County Council, Uppsala University, Uppsala, Sweden

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • University Hospitals of North Midlands NHS Trust, Stafford, United Kingdom

  • University Hospital Aintree, Liverpool, United Kingdom

  • GSK, Siena, Italy

Locations

  • United Kingdom

  • Sweden

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • NCT02075541

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved